GLP-1 Weight Loss Therapy
Both are GLP-1 receptor agonists - they mimic a hormone your gut releases when you eat, signaling fullness and slowing digestion. Tirzepatide goes a step further: it activates a second receptor (GIP) at the same time, which clinical evidence suggests produces stronger effects on appetite and weight reduction. Semaglutide has been around longer and has a longer track record. Your iLIFE doctor will recommend the one that fits your starting point and goals.
No. iLIFE prescribes compounded semaglutide and tirzepatide - formulations made by U.S. licensed compounding pharmacies under a doctor's prescription. These are not FDA-approved and are not substitutes for any FDA-approved brand-name medication. They're a separate category of treatment, with their own protocols and considerations. Your iLIFE doctor will explain the difference and help you decide if compounded GLP-1 therapy is right for you.
Generally: adults with weight-loss goals and a health profile your doctor determines is appropriate for GLP-1 therapy. The assessment will gather what we need; the doctor decides.
How GLP-1 actually works
When you eat, your gut releases a hormone called GLP-1. It tells your brain you're full, it slows how fast food leaves your stomach, and it helps your body release the right amount of insulin. In some people, that signal is weaker than it should be - which is why "just eat less" feels impossible no matter how disciplined you are.
GLP-1 medications activate the same receptors your body already uses. Compounded semaglutide and tirzepatide work like that natural signal, turned up. Cravings quiet down. Smaller portions actually feel like enough. The constant background hum of "what's in the fridge?" gets a lot quieter.
How it tends to feel
Cravings stop running the show
Smaller meals feel like enough
Fullness lasts hours, not minutes
Dieting feels less like a fight
How iLIFE works
Quick assessment
Doctor review and protocol
GLP-1 shipped to your door
Our medical team
Why iLIFE?
About the side effects.
Most people on GLP-1 medications experience some side effects. Nausea is the most common, especially in the first few weeks and after dose increases. It usually fades.
Your iLIFE doctor titrates your dose carefully to minimize this, and can prescribe ondansetron (an anti-nausea medication) if needed.
Less common side effects can include vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. Most are temporary. If anything persists or gets worse, you message your care team and we adjust.
Questions we hear all the time
That varies. Clinical evidence on the active ingredients in compounded semaglutide and tirzepatide suggests meaningful weight loss is possible for many patients, but your specific results depend on your starting weight, your protocol, your food and movement habits, and how consistent you are. Your doctor will set realistic expectations during your first review.
You don't have to overhaul anything. The medication does most of the heavy lifting on appetite, which makes the food choices easier on their own. We do recommend leaning toward higher-protein meals, because muscle is something you want to keep through weight loss.
Some patients regain weight when they stop GLP-1 medications. Others maintain. The best results come from working with your doctor on a tapering plan and using the time on the medication to build sustainable habits.
Compounded semaglutide and tirzepatide are typically self-injected once a week with a small needle. We provide written and video instructions. Most patients find it much easier than they expected.
The assessment takes a few minutes, doctor review usually happens same-day, and your medication ships within a few business days of approval.
Tired of fighting your own appetite?
The recognized brand-name medications Wegovy(r) and Ozempic(r) are manufactured by Novo Nordisk A/S. Zepbound(tm) and Mounjaro(r) are manufactured by Eli Lilly and Company(tm). iLIFE does NOT manufacture or distribute these medications and has no direct affiliation with Eli Lilly and Company(tm) or Novo Nordisk A/S.
The products offered by iLIFE are compounded medications prepared by U.S. licensed compounding pharmacies. These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medications. They are not intended to diagnose, treat, cure, or prevent any disease and are not substitutes for FDA-approved medications such as Mounjaro(r), Zepbound(tm), Wegovy(r), or Ozempic(r). Any claims regarding effectiveness or weight loss benefits relate only to general mechanisms of the active ingredients (e.g., semaglutide or tirzepatide) and do not pertain to iLIFE's specific compounded formulations. These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider. Product images are for illustration only. iLIFE is not the compounder or manufacturer.
